Trial Condition(s):

Hyperkinetic Syndorme

Effects of Lisuride and placebo on psychomotor instability syndrome in children

Bayer Identifier:

Trial_EXC008

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

May1975

May1976

Phase

N/A

Could I receive a placebo?

Products

Dopergin (Lisuride Hydrogen-Maleate, BAYR5936)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Hyperkinetic Syndorme

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

Trial Purpose

Key Participation Requirements

sex

age

5 Years

12 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information